Toxicological evaluation of protein powder derived from Cupriavidus necator

J Appl Toxicol. 2023 Jun;43(6):887-912. doi: 10.1002/jat.4432. Epub 2023 Jan 26.

Abstract

Microorganisms have the potential to produce nutrient-rich products that can be consumed as food or feed. The protein-rich powder derived from heat treatment of the whole-cell biomass of polyhydroxybutyrate-deficient Cupriavidus necator, a metabolically versatile organism that uses elements found in the air, is an example of such a product. To assess the safety of the protein powder for use as a nutritional ingredient in human food, in accordance with internationally accepted standards, its genotoxic potential and repeated-dose oral toxicity were investigated. A bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test were performed. No evidence of mutagenicity or genotoxicity was found. Additionally, a 90-day repeated-dose oral toxicity study in rats was completed, in which a total of 100 male and female Wistar rats were exposed by gavage to daily doses of 1000, 2000, or 3000 mg/kg bw/day of the test material. Following 90 days of continuous exposure, no mortality or treatment-related adverse effects were observed and no target organs were identified. Therefore, a no observed adverse effect level was determined at 3000 mg/kg bw/day, the highest dose tested.

Keywords: Cupriavidus necator; NOAEL; protein concentrate; single-cell protein; toxicity, genotoxicity, safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cupriavidus necator*
  • Female
  • Humans
  • Male
  • Mammals
  • Mutagenicity Tests
  • No-Observed-Adverse-Effect Level
  • Powders / toxicity
  • Rats
  • Rats, Wistar

Substances

  • Powders
  • polyhydroxybutyrate